ClearPoint Neuro Inc. (CLPT) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Clearpoint Neuro Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.394 Greetings, and welcome to the ClearPoint Neuro, Inc. 00:00:02.394 -- 00:00:06.901 fourth quarter and full year 2025 Financial Results Conference call. 00:00:06.901 -- 00:00:09.845 At this time, all participants are on a listen-only mode. 00:00:09.845 -- 00:00:13.687 A question and answer session will follow the formal presentation. 00:00:13.790 -- 00:00:18.437 If anyone should require operator assistance during the call, please press star zero 00:00:18.437 -- 00:00:20.500 on your telephone keypad. 00:00:20.500 -- 00:00:23.704 As a reminder, this conference is being recorded. 00:00:23.704 -- 00:00:27.269 Comments made on this call may include statements that are forward-looking within the 00:00:27.269 -- 00:00:31.888 meaning of securities laws. These full-looking statements may include, without limitation, 00:00:31.888 -- 00:00:36.998 statements related to anticipated industry trends, the company's plans, prospects, and 00:00:36.998 -- 00:00:42.229 strategies, both preliminary and projected, besides the total adjustable 00:00:42.229 -- 00:00:45.948 markets or the market opportunity for the company's products and services. 00:00:45.948 -- 00:00:51.376 the company's expectations regarding the integration, performance, and anticipated benefits 00:00:51.376 -- 00:00:57.185 of its recent acquisition of Eris Holdings Inc., including operational 00:00:57.185 -- 00:01:02.854 efficiencies and the impact of the company's financial condition and results of operations, 00:01:02.854 -- 00:01:08.242 the company's expectation for future development, regulatory approval, 00:01:08.242 -- 00:01:10.405 timing, commercialization, 00:01:10.405 -- 00:01:15.435 and the market for cell and gene therapies, and the anticipated adoption of 00:01:15.435 -- 00:...